Therapy for transthyretin-associated amyloidosis

It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in...

Full description

Saved in:
Bibliographic Details
Main Authors Insa Boronat, Raúl, Reig Bolaño, Nuria, Centellas Casado, Marc, Gavaldà Batalla, Núria
Format Patent
LanguageEnglish
Published 31.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.
AbstractList It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.
Author Centellas Casado, Marc
Gavaldà Batalla, Núria
Insa Boronat, Raúl
Reig Bolaño, Nuria
Author_xml – fullname: Insa Boronat, Raúl
– fullname: Reig Bolaño, Nuria
– fullname: Centellas Casado, Marc
– fullname: Gavaldà Batalla, Núria
BookMark eNrjYmDJy89L5WQwCMlILUosqFRIyy9SKClKzCsuyagsSi3JzNNNLC7OT85MLElNUUjMrczJz0zJL84s5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoamZiYWlpZORsbEqAEAwhkuPA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US11564899B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US11564899B23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:59:06 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US11564899B23
Notes Application Number: US202017005893
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230131&DB=EPODOC&CC=US&NR=11564899B2
ParticipantIDs epo_espacenet_US11564899B2
PublicationCentury 2000
PublicationDate 20230131
PublicationDateYYYYMMDD 2023-01-31
PublicationDate_xml – month: 01
  year: 2023
  text: 20230131
  day: 31
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies SOM INNOVATION BIOTECH, S.L
RelatedCompanies_xml – name: SOM INNOVATION BIOTECH, S.L
Score 3.4557629
Snippet It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Therapy for transthyretin-associated amyloidosis
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230131&DB=EPODOC&locale=&CC=US&NR=11564899B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVdH6IILkFkyazbYegpAXRegDm0hvZTe7gRRMi0np33c2ptaL3sIG9jEw8823u_MtwGOGXmBTaho9RoRBuM3VMy99gzHC2HOGGCJUofBoTIcJeZ078xYsd7UwtU7othZHRI9K0d-rOl6v95tYQX23snziOTatXqLYDfSGHWM-bWFQCTw3nE6Cia_7vpvM9PGbaylRFOQWHobrA5VGK5398N1TVSnr35ASncLhFHsrqjNoyaIDx_7u5bUOHI2aA2_8bHyvPAcz_hYA0DDN1CoFMWhjVYNYGKyxsRQa-0AGnotVmZcX8BCFsT80cOjFzzoXyWw_S_sS2sj_5RVogvGekw2YzJA9pJRygsDGMic1B31pU3IN3b_76f738wZOlM3UjoJt3UK7-tzIO8TYit_XxvkC17yCUg
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYqbtwrSt2K7pul8KEJvVF274VrZW0lvMMFu2Ip_35PaOV_0LSSQy4FzvnxJzheAmwK9QKVUlkaMZBJJ1IR_86JLjBHG7grEkIwnCvsB9SLyuNAWHXjd5MI0OqGfjTgielSK_l438Xq9PcSym7eV1W2yxKrVvRsattiyY9xPKxhUbNNwZlN7aomWZURzMXg2FC6KgtzCxHC9oyMl5Dr7zovJs1LWvyHFPYDdGfZW1ofQycs-9KzNz2t92PPbC28str5XHYEcfgsACLjNFGoOMWhjnoNYSqy1cZ4J7A0Z-DJbVcvqGK5dJ7Q8CYeOf9YZR_PtLNUT6CL_z09ByFgy0ooxywtkDymlCUFgY4WWymM9VykZwPDvfob_NV5Bzwv9STx5CJ7OYJ_bj58uqMo5dOv3j_wC8bZOLhtDfQEWOYU9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Therapy+for+transthyretin-associated+amyloidosis&rft.inventor=Insa+Boronat%2C+Ra%C3%BAl&rft.inventor=Reig+Bola%C3%B1o%2C+Nuria&rft.inventor=Centellas+Casado%2C+Marc&rft.inventor=Gavald%C3%A0+Batalla%2C+N%C3%BAria&rft.date=2023-01-31&rft.externalDBID=B2&rft.externalDocID=US11564899B2